Pharmamarketeer

5 volatile drug launches to watch in 2024

5 volatile drug launches to watch in 2024 After drinking from the firehose that is JPM week, I realized that those five were hardly the last word on launches. As for this most recent batch, all are expected to create...

CES 2024: The future of pharma advertising explored

CES 2024: The future of pharma advertising explored At the 2024 CES, the Consumer Technology Association’s annual trade show, there was plenty of boasting of tech that demonstrates the ongoing shift from straight...

FDA Drug Approval Decisions Expected in February 2024

FDA Drug Approval Decisions Expected in February 2024 The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or...

Top 5 healthcare moments of 2023

Top 5 healthcare moments of 2023 From a healthcare perspective, 2023 was all about a changing of the guard after years of operating in a pandemic mindset. COVID-19 transitioned from pandemicity to endemicity and as...

Medhc-fases-banner
Advertentie(s)